Back to BNN.DEView Full LandscapeView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
12 competitors in Major Depressive Disorder
ITCILumateperone
Phase 3LLYLY2216684
Phase 3TXMDREL-1017
Phase 3AXSMAXS-05 (dextromethorphan and bupropion) oral tablets
Phase 3XENEAzetukalner
Phase 3Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Inhaled isoflurane administered by Sedaconda ACD-SPhase 3
Post-Intensive Care Syndrome
Nerinetide (NA-1)Phase 3
Acute Cerebral Ischemia
ProgesteronePhase 3
Alcohol Dependence
Celecoxib 400mgPhase 3
Depressive Disorder, Major
0.5 mgTestosterone + 10 mg BuspironePhase 2
Hypoactive Sexual Desire Disorder
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts